Newsweek: Children’s Cancer Is Unprofitable and Ignored
“Childhood cancers make up less than 1 percent of all cancers diagnosed each year . . . not much of a market for drugmakers, who…
July 2015
Synthetic circuit designs for earth terraformation.
Via: Victor de Lorenzo (@vdlorenzo_CNB) “The issue is not to stop or slow down climatic change, but to revert it. SynBio bacteria may have the…
“Executing an open innovation model: Cooperation is key . . .” Deloitte Report
“Deloitte’s analysis of the current state of OI in biopharma reveals a higher success rate for OI pursuits than for closed-model product development. However, companies…
We Need a Github of Science
“Scientists make a big deal of peer- review, because it is supposed to be the filter that separates mere opinions from trusted, citable sources. However,…
In the News: Open Therapeutics’ First Non-Operating Sub (by Tauriga Sciences)
Tauriga Sciences Inc. Wholly Owned Subsidiary Pilus Energy LLC Executes Commercialization and Distribution Agreement with Singapore Based Naturo Energy Pte. Ltd. “The Agreement will be…
Virotherapy Shows Promise Against Highly Malignant Pediatric Tumors :: Nationwide Children’s Hospital
Virotherapy Shows Promise Against Highly Malignant Pediatric Tumors (From the July 2015 Issue of PediatricsOnline)
“Patents are a terrible way to measure innovation” – Washington Post
Patents are a terrible way to measure innovation, Dominic Basulto, The Washington Post (July 15, 2015). #OpenScience #OpenTherapeutics #OpenSource #SynBio #VC
National Institutes of Health (NIH) – Emerging Global Leader Award
The NIH Fogarty Emerging Global Leader Award provides research support to a junior faculty researcher from a low- or middle-income country (LMIC) academic or research…
